MET and neoplasm: To visualize in vivo c-MET expression and study the organ distribution of this anticalin, Terwisscha van Scheltinga and colleagues generated 89Zr-PRS-110 with a specific activity of 100 MBq/mg and radiochemical purity of >95% and assessed its specific uptake in different human tumor xenograft models.